Trial Profile
Ppar-Gamma EliminAtes Restenosis Longevity Study: PEARLS
Status:
Discontinued
Phase of Trial:
Phase III
Latest Information Update: 26 Jun 2023
Price :
$35
*
At a glance
- Drugs Rosiglitazone (Primary)
- Indications Metabolic syndrome
- Focus Pharmacodynamics
- Acronyms PEARLS
- 10 Jul 2007 New trial record.